Related Experiment Video
Updated: Aug 27, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
[Gender and sexual minorities: Unknowns in the cancer care pathway]
Arnaud Alessandrin1, Anastasia Medaini2, Jean-Pierre Droz3
1Université de Bordeaux, LACES, 3, terrasse place de la Victoire, 33000 Bordeaux, France.
Abstract:
The French National Cancer Institute, in its ten-year roadmap, has defined an axis 4: "ensuring that progress benefits all". The Association francophone sur les soins oncologiques de support wished to take stock of cancer care for gender and sexual minorities. The authors, who have a sociological and oncological background, have gathered the main data from the French-language literature limited to sociological aspects. They address the definitions of sexual orientation, identity and practice, gender identity, expression and assignment, and the issue of intersex. They report on the concrete problems from patients' narratives. Little research has been done on cancer patients. Studies on children and young adolescents focus on other issues (harassment, discrimination, dropping out of school); those on the older persons show the invisibility of the issue. For adults, the organization of the care process is obscured by a purely psychiatric and technical medical approach. The relationship of trust is not established, and the terms and views used lead to delays and breaks in care. To remedy these shortcomings, the authors suggest that training efforts be made (for patients and caregivers), that community associations be supported, and that sociological and medical research be carried out, considering an approach by cancer pathology as well as by sexual or gender minority groups.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Cancer Survival Analysis
mTOR Signaling and Cancer Progression
The mTOR pathway or the...